A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104.
- Citation:
- J Thorac Oncol vol 4 (2) 220-6
- Year:
- 2009
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 802
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- CA31946, CA33601
- Corr. Author:
- Authors:
- Ramaswamy Govindan Xiaofei Wang Maria Q Baggstrom Susan Burdette-Radoux Lydia Hodgson Everett E Vokes Mark R Green
- Networks:
- Study
- CALGB-30104
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Etoposide, Female, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasm Staging, Prognosis, Small Cell Lung Carcinoma, Sulindac, Survival Rate, Treatment Outcome